Silo Brook Capital (“SBC”) is a Boston based private equity firm specialized in acquiring and scaling small-cap nutraceutical direct-to-consumer (“DTC”) brands distributing on the Amazon.com platform.
SBC’s investment philosophy for its nutraceutical buyouts platform fosters around three key principles: (1) Identifying & investing in brands with proven economic moats on the Amazon platform; (2) targeting category leaders within niche markets with double digit market growth attractive for future acquisitions; and (3) exclusively acquiring brands that have the potential to distribute within big-box retail stores such as GNC, Vitamin Shoppe, Walgreens & CVS.
Company Details
- Employees
- 1
- Address
- 1 Franklin St, Boston,massachusetts 02110,united States
- Industry
- Financial Services
- NAICS
-
Finance and InsuranceMonetary Authorities-Central Bank
- Website
- https://silobrookcapital.com
- Keywords
- Boston.
- HQ
- Boston, Massachusetts
Silo Brook Capital Questions
Silo Brook Capital's website is https://silobrookcapital.com
Silo Brook Capital's LinkedIn profile is https://www.linkedin.com/company/silobrookcapital
Silo Brook Capital has
1 employees.
View email and phone details for 1
employees at Silo Brook Capital.
Silo Brook Capital's industry is
Financial Services
Silo Brook Capital's top competitors are
Castlesquare,
Azoth Llc,
Met Boston Inc.,
Patterson Real Estate Advisory Group,
Renegade Capital,
Endeavor Advisory Group,
The Tewarie Group,
Walker & Dunlop,
Supplement Snoop,
Tewarie Enterprises & Ventures.
Silo Brook Capital's categories are Financial Services
